Enveric Biosciences (ENVB) Convertible Debt (2015 - 2018)
Enveric Biosciences (ENVB) posted Convertible Debt of $1.2 million for Q3 2018, little changed sequentially from $1.2 million in Q2 2018, and little changed YoY from $1.2 million in Q3 2017.
Enveric Biosciences (ENVB) Convertible Debt (2015 - 2018) Analysis & Trends
Enveric Biosciences has reported Convertible Debt for 4 years, with the latest figure at $1.2 million in Q3 2018.
- Quarterly Convertible Debt changed 0.0% year-over-year to $1.2 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $1.2 million (changed 0.0% YoY) and the FY2017 annual result came in at $1.2 million, changed N/A from the prior year.
- Convertible Debt steadied at $1.2 million in Q3 2018 per ENVB's latest filing, from $1.2 million in the prior quarter.
- Over five years, Convertible Debt peaked at $5.0 million in Q3 2015 and troughed at $1.2 million in Q1 2017.
- A 4-year average of $2.8 million and a median of $1.2 million in 2017 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2016 and 2017: Convertible Debt changed 0.0% in 2016, then plunged 75.0% in 2017.
- Over 4 years, Convertible Debt stood at $5.0 million in 2015, then changed by 0.0% to $5.0 million in 2016, then slumped by 75.0% to $1.2 million in 2017, then changed by 0.0% to $1.2 million in 2018.
- According to Business Quant data, Convertible Debt over the past three periods registered $1.2 million, $1.2 million, and $1.2 million for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 1.25 Mn |
| Jun 30, 2018 | 1.25 Mn |
| Mar 31, 2018 | 1.25 Mn |
| Dec 31, 2017 | 1.25 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Jun 30, 2017 | 1.25 Mn |
| Mar 31, 2017 | 1.25 Mn |
| Sep 30, 2016 | 5.00 Mn |
| Jun 30, 2016 | 5.00 Mn |
| Mar 31, 2016 | 5.00 Mn |
| Dec 31, 2015 | 5.00 Mn |
| Sep 30, 2015 | 5.00 Mn |